Cancer is a life threatening disease and thus interrupts the balance in a person´s life. It is well known that some of those who are diagnosed with cancer seemingly are more successful in processing and adapting to the life threat, the cancer, and it´s treatments, than others. This outcome cannot be explained by the severity of the cancer or the demanding treatment, but has been shown to correlate to the psychological resilience.
Within the MAD for Cancer Program we aim to understand the body and mind interaction to promote cancer treatment. We will for the first time, investigate if the patient´s psychological behavior, so called psychological resilience, could be coupled to bio-molecular parameters, using advanced “omics”, and thus be coupled to treatment outcome. We will also explore the impact from psychological resilience on quality of life.
At the time of diagnosis, patients are subjected to a bio-psychosocial and quality of life assessment and standard chemical testing focusing on e.g. stress hormones, inflammatory factors etc. In addition, using the knowledge of the MAD for Cancer Proteomics team, serum samples will be analyzed using advanced proteomics and affinity proteomics technologies to identify biomarker signatures associated with the assessed high vs. low resilience parameters. Revealing the body-mind interaction will open up for developing personalized psychosocial care and treatments strategies.